CrossrefInfokarte
Comment on “The Advanced Lung Cancer Inflammation Index as a Prognostic Indicator in Patients With Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy”
Hepatology Research · 2026-11 · 56 (11) · 1763-1764
DOI: 10.1111/hepr.70227 ↗Abstract
Kein Abstract verfügbar.
EUVIMED